Galen
Pharmaceutical company that licenses, acquires and commercialises late-stage and ready-to-market medicines for healthcare providers
Highlights
- New on EvolcAdded 2026-10-29
About Galen
Galen is a privately owned pharmaceutical company that supports products across their full commercial lifecycle, from market entry through to long-term supply and product management. It works through licensing and acquisition arrangements for late-stage and ready-to-market pharmaceutical products.
Its partners are pharmaceutical companies with products in late-stage development or close to market. Core operations are in the UK and Ireland. POA Pharma, acquired in 2020, is headquartered in Copenhagen and operates across Denmark, Sweden, Finland, Norway, Iceland, Germany, Austria and the Netherlands. The website describes Galen as having global partners on every continent and lists 65+ products and 30+ trusted partners.
Galen was established in 1968 in Northern Ireland, and the legal entity Galen Limited was founded in 2005. The company is owned by the McClay Foundation, according to its website.
Product: Pharmaceutical product licensing, acquisition and commercialisation services, covering market entry, supply and lifecycle management.
Jobs at Galen
Leadership
- Dennise Broderick · Managing Director and PresidentSource: company website
- Simon Lawrence · Vice President, Marketing and Medical NutritionSource: company website
- Louise Mulholland · Head of Commercial OperationsSource: company website
More biotech & pharma companies
Gedeon Richter (UK)
Pharmaceutical products for women’s health and other specialist therapy areas, serving patients and healthcare professionalsNew on EvolcGenedrive PLC
Point-of-care pharmacogenetic tests for NHS clinicians, including antibiotic and antiplatelet treatment kitsNew on EvolcGenetix Research
Genetic research and vaccine development company offering manufacturing services for medical and healthcare clients in the UKYoung companyNew on EvolcGenomics
Genomic analytics and disease-risk tools for pharmaceutical companies, healthcare providers, employers and individualsRemote-friendlyGrunenthal
Pain medicines and related treatment solutions for healthcare professionals and patients in the UKNew on EvolcGylden Pharma
Develops intradermal drug-delivery and immune-activation platforms for migraine treatment, vaccines and oncologyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- Google reCAPTCHA
- HubSpot
- Tailwind CSS
- WordPress
- jQuery